This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GRNA GreenLight Biosciences (GRNA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About GreenLight Biosciences Stock (NASDAQ:GRNA) 30 days 90 days 365 days Advanced Chart Get GreenLight Biosciences alerts:Sign Up Key Stats Today's Range$0.30▼$0.3050-Day Range$0.30▼$0.3052-Week Range$0.18▼$5.90Volume732 shsAverage Volume486,986 shsMarket Capitalization$45.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview FUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV. Read More Receive GRNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GRNA Stock News HeadlinesGreenlight Coupon CodesApril 21, 2024 | washingtonpost.comSplashdown Quaywest gets green light for £3m upgradeDecember 20, 2023 | bbc.comBYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.July 21 at 2:00 AM | Priority Gold (Ad)Broadwalk Shopping Centre redevelopment given green lightSeptember 28, 2023 | bbc.comBGreenlight Family Cash Card 2023 ReviewSeptember 19, 2023 | forbes.comGreenLight Biosciences: GreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finanznachrichten.deGreenLight Announces Completion of Merger with Fall Line Endurance FundJuly 24, 2023 | finance.yahoo.comGreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding SharesJuly 20, 2023 | finance.yahoo.comSee More Headlines GRNA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of GreenLight Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that GreenLight Biosciences investors own include Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL), abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), Meta Platforms (META), NVIDIA (NVDA) and Blue Owl Capital (OBDC). Company Calendar Today7/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRNA CIK1822691 Webwww.eiacorp.com Phone(760) 809-8079FaxN/AEmployees280Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$167.05 million Net Margins-1,521.00% Pretax Margin-1,510.44% Return on Equity-374.26% Return on Assets-122.78% Debt Debt-to-Equity Ratio0.49 Current Ratio1.21 Quick Ratio1.21 Sales & Book Value Annual Sales$10.20 million Price / Sales4.45 Cash FlowN/A Price / Cash FlowN/A Book Value$0.32 per share Price / Book0.94Miscellaneous Outstanding Shares151,681,000Free Float105,722,000Market Cap$45.43 million OptionableNot Optionable Beta1.44 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:GRNA) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GreenLight Biosciences Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share GreenLight Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
